AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Parent-led Assessment and Recognition of AOM Using Digital Ear Imaging

RecruitingNAAges 12 Months - 47 MonthsAllTurku University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute otitis media (AOM) is the most common bacterial infection in young children and a major contributor to healthcare utilization and costs. Diagnosis relies on otoscopy and identification of tympanic membrane (TM) bulging, yet physician-performed otoscopy has variable diagnostic accuracy and depends heavily on clinical expertise. Digital otoscopy combined with artificial intelligence (AI)-based image analysis has demonstrated high diagnostic accuracy in previous studies. In a recent study by our group, digital otoscopy with an automated neural network classifier reliably ruled out otitis media in children. The PARENT-EAR randomized controlled pilot trial aims to evaluate whether parent-performed digital otoscopy at home, combined with retrospective AI analysis of captured TM images, can reduce physician visits due to suspicion of AOM. The study also assesses feasibility, diagnostic

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * At least one episode of AOM within the last 12 months * Family speaks fluent Finnish Exclusion Criteria: * Tympanostomy tubes or perforation of the TM, or scheduled for upcoming tympanostomy * Middle ear fluid at the time of recruitment * Previously diagnosed hearing loss * Immunosuppressive disorder or medication, excluding inhaled corticosteroids * Anatomic defect or anomaly affecting the susceptibility to AOM * Previous otoscopy experience of the participating parent
๐Ÿ’Š

What it tests

  • Assigning of a digital otoscope to the families in the intervention group
๐Ÿ“

Where

2 sites
Vaasa Central Hospital
Vaasa, Finland
Turku University Hospital
Turku, Finland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy